Re-submission to FDA was Dec19 and it is either 8 month approval timeline (if no site inspection required) or 10 month timeline (if site inspection is required). Investor relations said that a site inspection was completed in the first round of review (prior to complete response letter). I suspect given that, no site inspection this time (they physically can't do it with COVID travel restrictions anyway) so targeting Aug/Sep approval. My opinion based on publicly known information.
MYX Price at posting:
42.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)